HRT Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

HRT Financial’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,356	Closed	-$144K	–	4989
2025 Q4	$144K	Buy	+17,356	New	+$96.2K	﹤0.01%	2715
2025 Q2	–	Sell	-4,148	Closed	-$18K	–	3665
2025 Q1	$18K	Sell	4,148 -3,138	-43%	-$20.3K	﹤0.01%	2314
2024 Q4	$51K	Buy	7,286 +2,438	+50%	+$26.8K	﹤0.01%	2109
2024 Q3	$70K	Buy	+4,848	New	+$218K	﹤0.01%	2076
2023 Q2	–	Sell	-2,646	Closed	-$172K	–	3404
2023 Q1	$172K	Buy	+2,646	New	+$160K	﹤0.01%	1957
2022 Q4	–	Sell	-1,141	Closed	-$33K	–	3266
2022 Q3	$33K	Buy	1,141 +126	+12%	+$4.32K	﹤0.01%	2464
2022 Q2	$19K	Buy	+1,015	New	+$51K	﹤0.01%	2613

Other funds holding VRCA

Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return

Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return

Cannell Capital Alta, Wyoming $154M AUM 40.62% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return